What is CUSIP 05368M106?

CUSIP 05368M106 is the security identifier used in SEC filing datasets for CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share.

Security Snapshot

Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO) Institutional Ownership

Q: Who owns CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: 05368M106

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$12.49

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Type / Class: Equity / Common Stock, par value $0.001 per share
Symbol: CDMO
Shares outstanding: 64,369,712
Price per share: $12.49

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Key facts

CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 05368M106.
Latest finished 13F holder period is not available.
1 significant owner is listed from Schedule 13D/13G reporting.

Change

Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
Reported value moved from $1,531,725 to $0.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

05368M106

Latest holder period

n/a

13F holders

13D/G owners

CIK / CUSIP context first

CDMO full holder history Avid Bioservices, Inc. SEC filings Avid Bioservices, Inc. company facts Avid Bioservices, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 05368M106:

Q4 2025 (0 holders) Q3 2025 (1 holder) Q2 2025 (0 holders) Q1 2025 (2 holders) Q4 2024 (195 holders) Q3 2024 (171 holders) Q2 2024 (167 holders) Q1 2024 (162 holders) Q4 2023 (171 holders) Q3 2023 (166 holders)

Significant Owners of Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
AltraVue Capital, LLC	5.9%		$47,190,485		3,797,813		AltraVue Capital, LLC	31 Dec 2024

Institutional Holders of Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	0	$0	-$1,531,725			$12.49	0
2025 Q3	134,598	$1,531,725	+$1,531,725			$11.38	1
2025 Q2	0	$0	-$2,310			$12.49	0
2025 Q1	187	$2,310	-$824,589,287	$0	$0	$12.43	2
2024 Q4	67,862,725	$838,118,292	+$9,853,050	$56,810	$2,661,425	$12.35	195
2024 Q3	68,016,155	$773,947,096	+$65,075,263	$1,345,850	$1,023,062	$11.38	171
2024 Q2	65,072,173	$464,610,616	+$2,556,922	$787,542	$152,082	$7.14	167
2024 Q1	65,068,905	$435,959,854	+$52,291,806	$680,050	$338,350	$6.70	162
2023 Q4	57,332,577	$373,979,029	-$54,052,092	$81,900	$172,900	$6.50	171
2023 Q3	62,604,660	$590,964,703	-$26,582,219	$45,312	$55,696	$9.44	166
2023 Q2	64,851,861	$906,098,576	-$203,208	$608,477	$300,355	$13.97	164
2023 Q1	64,584,658	$1,211,388,533	-$7,196,779	$960,512	$671,608	$18.76	166
2022 Q4	65,304,421	$899,318,344	+$3,894,302	$363,528	$414,477	$13.77	162
2022 Q3	64,309,645	$1,229,047,447	+$30,714,400	$80,000	$533,000	$19.12	168
2022 Q2	61,099,678	$932,609,878	-$12,928,155	$252,000	$154,000	$15.26	180
2022 Q1	61,944,273	$1,262,212,725	-$11,767,975	$0	$4,007,000	$20.37	182
2021 Q4	61,292,159	$1,785,416,483	+$224,167,054	$306,000	$3,838,000	$29.18	184
2021 Q3	53,889,335	$1,161,457,403	+$19,405,092	$0	$5,336,000	$21.57	154
2021 Q2	52,834,820	$1,353,592,887	+$137,037,774	$4,364,000	$5,690,000	$25.65	167
2021 Q1	47,706,252	$870,108,293	+$164,156,116	$261,000	$2,536,000	$18.23	152
2020 Q4	39,269,337	$453,350,286	+$67,918,429	$268,000	$355,000	$11.54	141
2020 Q3	33,338,151	$254,061,025	+$32,454,270	$358,000	$376,000	$7.62	104
2020 Q2	29,117,143	$191,764,644	+$5,672,161	$425,000	$782,000	$6.56	95
2020 Q1	28,279,005	$144,444,796	-$6,179,021	$202,000	$237,000	$5.11	89
2019 Q4	28,687,052	$219,999,260	+$25,179,108	$93,000	$539,000	$7.67	105
2019 Q3	25,297,730	$133,946,899	+$6,955,012	$64,000	$201,000	$5.30	90
2019 Q2	23,840,831	$133,510,921	+$16,544,433		$216,000	$5.60	86
2019 Q1	21,669,771	$92,077,139	-$4,951,613		$136,000	$4.25	88
2018 Q4	22,411,743	$91,847,919	+$1,141,125	$0	$117,000	$4.10	93
2018 Q3	16,666,361	$114,325,369	+$33,609,807	$525,000	$403,000	$6.86	93
2018 Q2	12,063,396	$47,294,157	+$7,659,118	$362,000	$126,000	$3.92	68
2018 Q1	10,528,593	$30,755,800	+$28,250,800	$94,000	$185,000	$2.92	56
2017 Q4	257,323	$993,000	+$958,000			$3.87	3
2016 Q2	0	$0	-$17,000			$12.49	0
2016 Q1	4,000	$17,000				$4.25	1